<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors" Version="20181019" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">Proposed model for regulation of MSMP expression in cancer cells under hypoxic conditions and the proangiogenic role of MSMP in ovarian tumors.

The recruitment of the transcriptional repressor CTCF to the MSMP enhancer region is regulated by changes in H3 acetylation of the MSMP enhancer. In hypoxic conditions, the repressor-enhancer binding is disrupted, leading to increased expression of MSMP. Secretion of MSMP triggers MAPK signaling in endothelial cells (presumably via CCR2 signaling), which promotes angiogenesis. 

This suggests that MSMP inhibition in combination with antiangiogenesis drugs (anti-VEGF) could be a new strategy to overcome resistance to antiangiogenesis therapy.

Description adapted from Mitamura et al.</Comment>
  <BiopaxRef>a27</BiopaxRef>
  <Graphics BoardWidth="829.0" BoardHeight="587.0"/>
  <DataNode TextLabel="MAPK Signaling" GraphId="cc697" Type="Pathway">
    <Graphics ShapeType="None" Color="14961e"/>
    </DataNode>
  <DataNode TextLabel="CCR2" GraphId="cfb00" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="Angiogenesis" GraphId="fbde6" Type="Pathway">
    <Graphics ShapeType="None" Color="14961e"/>
    </DataNode>
  <DataNode TextLabel="MSMP" GraphId="d1da7" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="CTCF" GraphId="fdaf6" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="CCR2" GraphId="f027b" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="MSMP" GraphId="f82fe" Type="GeneProduct">
        </DataNode>
  <Interaction>
    <Graphics>
      <Point GraphRef="fdaf6"/>
      <Point GraphRef="c331b" ArrowHead="mim-binding"/>
      <Anchor Position="0.4" Shape="None" GraphId="c66f9"/>
    </Graphics>
    </Interaction>
  <Interaction>
    <Graphics>
      <Point GraphRef="b3123"/>
      <Point GraphRef="c66f9" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction>
    <Graphics LineStyle="Broken">
      <Point GraphRef="cc697"/>
      <Point GraphRef="fbde6" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="d1da7"/>
      <Point GraphRef="f027b" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction>
    <Graphics>
      <Point GraphRef="ba295"/>
      <Point GraphRef="f82fe" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    </Interaction>
  <Interaction>
    <Graphics>
      <Point GraphRef="f027b"/>
      <Point GraphRef="cc697" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction>
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="f82fe"/>
      <Point GraphRef="d1da7" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e528d">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="d1da7"/>
      <Point GraphRef="cfb00" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <GraphicalLine GroupRef="b470e">
    <Graphics>
      <Point/>
      <Point/>
    </Graphics>
  </GraphicalLine>
  <Label TextLabel="Hypoxia" GraphId="b3123">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Enhancer" GraphId="c331b" GroupRef="b470e">
    <Graphics FillColor="ffffff" ShapeType="RoundedRectangle"/>
  </Label>
  <Shape TextLabel="Tumor cell" GraphId="ae571">
    <Graphics ShapeType="RoundedRectangle" Color="c0c0c0"/>
  </Shape>
  <Shape TextLabel="Nucleus" GraphId="eaca3">
    <Graphics ShapeType="Oval" Color="c0c0c0"/>
  </Shape>
  <Shape TextLabel="Endothelial cell" GraphId="fa129">
    <Graphics ShapeType="RoundedRectangle" Color="c0c0c0"/>
  </Shape>
  <Group GroupId="b470e" GraphId="ba295" Style="Group"/>
  <InfoBox/>
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a27">
      <bp:ID >29059175</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP).</bp:TITLE>
      <bp:SOURCE >Oncogene</bp:SOURCE>
      <bp:YEAR >2018</bp:YEAR>
      <bp:AUTHORS >Mitamura T</bp:AUTHORS>
      <bp:AUTHORS >Pradeep S</bp:AUTHORS>
      <bp:AUTHORS >McGuire M</bp:AUTHORS>
      <bp:AUTHORS >Wu SY</bp:AUTHORS>
      <bp:AUTHORS >Ma S</bp:AUTHORS>
      <bp:AUTHORS >Hatakeyama H</bp:AUTHORS>
      <bp:AUTHORS >Lyons YA</bp:AUTHORS>
      <bp:AUTHORS >Hisamatsu T</bp:AUTHORS>
      <bp:AUTHORS >Noh K</bp:AUTHORS>
      <bp:AUTHORS >Villar-Prados A</bp:AUTHORS>
      <bp:AUTHORS >Chen X</bp:AUTHORS>
      <bp:AUTHORS >Ivan C</bp:AUTHORS>
      <bp:AUTHORS >Rodriguez-Aguayo C</bp:AUTHORS>
      <bp:AUTHORS >Hu W</bp:AUTHORS>
      <bp:AUTHORS >Lopez-Berestein G</bp:AUTHORS>
      <bp:AUTHORS >Coleman RL</bp:AUTHORS>
      <bp:AUTHORS >Sood AK</bp:AUTHORS>
    </bp:PublicationXref>
  <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#"><bp:TERM>ovarian cancer</bp:TERM><bp:ID>DOID:2394</bp:ID><bp:Ontology>Disease</bp:Ontology></bp:openControlledVocabulary><bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#"><bp:TERM>CC chemokine mediated signaling pathway</bp:TERM><bp:ID>PW:0000831</bp:ID><bp:Ontology>Pathway Ontology</bp:Ontology></bp:openControlledVocabulary><bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#"><bp:TERM>endothelial cell</bp:TERM><bp:ID>CL:0000115</bp:ID><bp:Ontology>Cell Type</bp:Ontology></bp:openControlledVocabulary><bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#"><bp:TERM>cancer pathway</bp:TERM><bp:ID>PW:0000605</bp:ID><bp:Ontology>Pathway Ontology</bp:Ontology></bp:openControlledVocabulary></Biopax>
</Pathway>